EUVIMEDEUVIMED entdecken
Crossref

The Protective Potential of Butyrate against Colon Cancer Cell Migration and Invasion Is Critically Dependent on Cell Type

Sema Oncel, Bryan D Safratowich, Huawei Zeng iD

Molecular Nutrition & Food Research · 2024

DOI: 10.1002/mnfr.202400421 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Nutrition & Food Research, 2024. Verfasst von Sema Oncel und 2 weiteren Autor:innen. Beteiligte Einrichtung: United States Department of Agriculture, Agricultural Research Service, Grand Forks Human Nutrition Research Center, Grand Forks, ND, 58203, USA. Hauptthemen laut MEDLINE: Cell Movement, Butyrates, Cadherins, Colonic Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: USDA CRIS PROJECT.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Scope Short‐chain fatty acids such as butyrate are produced through the fermentation of dietary fiber by colonic bacteria. Preclinical studies indicate an anticancer potential of butyrate, but clinical evidence shows greater variability. The study hypothesizes the effectiveness of butyrate on reducing colon cancer cell migration and invasion may vary due to the cell‐type. Methods and results The study determines the efficacy of butyrate (0–4 mM) to inhibit cancer cell migration, invasion, and related signaling proteins in three distinct human colorectal cancer (CRC) cell lines: HCT116, HT‐29, and Caco‐2. Butyrate exhibits a dose‐dependent inhibitory effect on cancer cell migration and invasion. This inhibitory potential on oncogenic focal adhesion kinase (FAK) and sarcoma (Src) proteins is greater in HCT116 cells (1.1 and 0.8‐fold) and HT‐29 cells (0.9 and 0.4‐fold) compared to Caco‐2 cells, respectively. Conversely, E‐cadherin protein, a classical epithelial cell marker and potential tumor suppressor, is 2.3‐fold greater in HCT116 cells than in HT‐29 cells and Caco‐2 cells. Moreover, survival analysis from a public cancer database demonstrates that CRC patients with high E‐cadherin expression have a 13% greater 5‐year survival rate than those with low expression. Conclusion Collectively, butyrate's anti‐cancer efficacy on CRC cells varies depending on cell‐type and is linked to the FAK/Src/E‐cadherin pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell MovementButyratesCadherinsColonic NeoplasmsHumansHT29 CellsCaco-2 CellsHCT116 CellsNeoplasm InvasivenessFocal Adhesion Protein-Tyrosine KinasesFocal Adhesion Kinase 1Antigens, CD

Stichwörter der Autor:innen

butyratecancerinvasionmetastasismigrationproliferation

Substanzen

ButyratesCadherinsPTK2 protein, humanFocal Adhesion Protein-Tyrosine KinasesFocal Adhesion Kinase 1CDH1 protein, humanAntigens, CD

Autor:innen und Institutionen

  • United States Department of Agriculture, Agricultural Research Service, Grand Forks Human Nutrition Research Center, Grand Forks, ND, 58203, USA.

ORCID-Profile: Huawei Zeng

Förderung

  • USDA CRIS PROJECT

Zitieren

APA

Oncel, S., Safratowich, B. D., & Zeng, H. (2024). The Protective Potential of Butyrate against Colon Cancer Cell Migration and Invasion Is Critically Dependent on Cell Type. Molecular Nutrition & Food Research. https://doi.org/10.1002/mnfr.202400421

Vancouver

Oncel S, Safratowich BD, Zeng H. The Protective Potential of Butyrate against Colon Cancer Cell Migration and Invasion Is Critically Dependent on Cell Type. Molecular Nutrition & Food Research. 2024. doi:10.1002/mnfr.202400421

BibTeX
@article{Oncel2024,
  author = {Oncel, Sema and Safratowich, Bryan D and Zeng, Huawei},
  title = {The Protective Potential of Butyrate against Colon Cancer Cell Migration and Invasion Is Critically Dependent on Cell Type},
  journal = {Molecular Nutrition & Food Research},
  year = {2024},
  doi = {10.1002/mnfr.202400421}
}
Kostenlos starten →